Aripiprazole recalls
Aripiprazole products have been recalled 13 times, most recently on 24 Jun 2026. The recalling company is usually Accord Healthcare. The most common reason is manufacturing (cgmp) deviations.
Total recalls13since 2018
Last 12 months2reported
Class I00% of total
Ongoing3latest 24 Jun 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 13 100%Class III 0 0%
Why aripiprazole is recalled
Companies
By year
Ongoing aripiprazole recalls
3 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Aripiprazole Tablets recalled by Ajanta Pharma USAAripiprazole | Ajanta Pharma USA | Packaging Defects | Nationwide |
| Drug | CLASS II | Aripiprazole Tablets, USP, 10 mg recalled by Ascend LaboratoriesAripiprazole | Ascend Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Aripiprazole Tablets, USP, 20 mg recalled by Ascend LaboratoriesAripiprazole | Ascend Laboratories | Potency & Assay | Nationwide |
All aripiprazole recalls, newest first
13 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.